Abstract:The ever-growing drug resistance problem worldwide highlights the urgency to discover and develop new drugs. Microbial natural products are a prolific source of drugs. Genome sequencing has revealed a tremendous amount of uncharacterized natural product biosynthetic gene clusters (BGCs) encoded within microbial genomes, most of which are cryptic or express at very low levels under standard culture conditions. Therefore, developing effective strategies to awaken these cryptic BGCs is of great interest for natural product discovery. In this study, we designed and validated a Transcription–Translation in One (TTO) approach for activation of cryptic BGCs. This approach aims to alter the metabolite profiles of target strains by directly overexpressing exogenous rpsL (encoding ribosomal protein S12) and rpoB (encoding RNA polymerase β subunit) genes containing beneficial mutations for natural product production using a plug-and-play plasmid system. As a result, this approach bypasses the tedious screening work and overcomes the false positive problem in the traditional ribosome engineering approach. In this work, the TTO approach was successfully applied to activating cryptic BGCs in three Streptomyces strains, leading to the discovery of two aromatic polyketide antibiotics, piloquinone and homopiloquinone. We further identified a single BGC responsible for the biosynthesis of both piloquinone and homopiloquinone, which features an unusual starter unit incorporation step. This powerful strategy can be further exploited for BGC activation in strains even beyond streptomycetes, thus facilitating natural product discovery research in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00581?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00581</a>.Methods and materials, including strains, plasmids, chemicals, strain manipulation, cultivation and fermentation conditions, isolation and characterization of natural products from activated biosynthetic pathways, bioactivity assay, genome sequencing, gene overexpression and gene deletions (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00581/suppl_file/cb0c00581_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Activation and discovery of tsukubarubicin from Streptomyces tsukubaensis through overexpressing SARPs

A Versatile Transcription–Translation in One Approach for Activation of Cryptic Biosynthetic Gene Clusters

Genome mining of Streptomyces sp. BRB081 reveals the production of the antitumor pyrrolobenzodiazepine sibiromycin

Genome mining-directed activation of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis.

Complete genome sequencing and in silico genome mining reveal the promising metabolic potential in Streptomyces strain CS-7

Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

Recent Advances in Silent Gene Cluster Activation in Streptomyces

Rational Engineering of Secondary Metabolic Pathways in a Heterologous Host to Enable the Biosynthesis of Hibarimicin Derivatives with Enhanced Anti-Melanomic Activity

Activation of Anthrachamycin Biosynthesis in Streptomyces Chattanoogensis L10 by Site-Directed Mutagenesis of Rpob

OSMAC-Based Discovery and Biosynthetic Gene Clusters Analysis of Secondary Metabolites from Marine-Derived Streptomyces globisporus SCSIO LCY30

Activation and Characterization of Lanthomicins A–C by Promoter Engineering in Streptomyces chattanoogensis L10

A Regulator Based “Semi-Targeted” Approach to Activate Silent Biosynthetic Gene Clusters

Identification of the Streptothricin and Tunicamycin Biosynthetic Gene Clusters by Genome Mining in Streptomyces Sp. Strain Fd1-Xmd

Genomic Analysis of Kitasatospora setae to Explore Its Biosynthetic Potential Regarding Secondary Metabolites

Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A

Genome mining of novel rubiginones from Streptomyces sp. CB02414 and characterization of the post-PKS modification steps in rubiginone biosynthesis

Genome mining of Streptomyces xinghaiensis NRRL B-24674T for the discovery of the gene cluster involved in anticomplement activities and detection of novel xiamycin analogs

Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria

Production of chain-extended cinnamoyl compounds by overexpressing two adjacent cluster-situated LuxR regulators in Streptomyces globisporus C-1027

Activation and Identification of a Griseusin Cluster in Streptomyces sp. CA-256286 by Employing Transcriptional Regulators and Multi-Omics Methods